Company intelligence / Profile preview
Rasna Therapeutics
United Statesrasna.com ↗
- Ownership
- Public · RASP
- Development stage
- Other
01
Overview
Rasna Therapeutics was a biotechnology company focused primarily on developing novel therapeutics for acute myeloid leukemia and other leukemias. The company's approach centered around small molecule drugs targeting epigenetic mechanisms implicated in these cancers. As per the most recent public information, their programs were at preclinical or early clinical stages with no reported late-stage trial results or approved products.
- Therapeutic areas
- OncologyHematology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Rasna Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rasna Therapeutics.